Robert E. Richard
Boston Scientific Corporation
48 Papers
1K Citations
Robert E. Richard is an academic researcher from Boston Scientific Corporation. The author has contributed to research in topics: Polymer & Copolymer. The author has an hindex of 21, co-authored 48 publications. Previous affiliations of Robert E. Richard include University of Oxford & Johnson & Johnson.
Chat about Author
Papers
Patent
Medical devices for delivery of therapeutic agents
Maria Palasis,Wendy Naimark,Robert E. Richard +2 more
- 03 Dec 2003
TL;DR: In this paper, the authors defined a class of medical devices that are at least partially insertable or implantable into the body of a patient. And they defined a set of methods of making such medical devices.
194
Styrenic block copolymers for biomaterial and drug delivery applications.
TL;DR: Poly (styrene-b-isobutylene- b-styrene) block copolymer has critical enabling properties related to processing, vascular compatibility and bio-stability that has resulted in its use as the matrix for paclitaxel delivery from Boston Scientific's TAXUS coronary stent.
132
Patent
Implantable or insertable medical devices containing graft copolymer for controlled delivery of therapeutic agents
Robert E. Richard,Frederick H. Strickler +1 more
- 29 Jul 2004
TL;DR: In this article, the authors described implantable or insertable medical devices comprising a therapeutic agent and a polymeric release region that controls the release of the therapeutic agent upon administration to a patient.
100
Patent
Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
Robert E. Richard,Frederick H. Strickler,Marlene C. Schwarz,Rodolf Faust,Ranade V. Shrirang,Michael N. Helmus +5 more
- 01 Feb 2006
TL;DR: In this paper, phase separated polymeric regions and their use in conjunction with implantable or insertable medical devices are discussed. But none of these regions can be used to produce the nanoporous polymeric region.
97
Controlled delivery of paclitaxel from stent coatings using poly(hydroxystyrene-b-isobutylene-b-hydroxystyrene) and its acetylated derivative.
Laszlo Sipos,Abhijit Som,Rudolf Faust,Robert E. Richard,Marlene Schwarz,Shrirang V. Ranade,Mark Boden,Ken Chan +7 more
TL;DR: It was concluded that the hydrophilic nature of the endblocks and polarity effects on the drug/polymer miscibility lead to enhanced release of PTx from these polymers.
79